Stay updated on Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial
Sign up to get notified when there's something new on the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page.

Latest updates to the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications section updated to state that publications are automatically filled from PubMed and may not be about the study. The previous wording described PubMed publications differently.SummaryDifference0.1%

- Check27 days agoChange DetectedThe funding/operating-status notice text has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedLocation label changed from Santiago de Cali, Colombia to Cali, Colombia in the study sites.SummaryDifference0.6%

- Check70 days agoChange Detected- Added a government-funding operating status notice and confirmation that the NIH Clinical Center is open; directs users to updated operating-status sources. - Bumped revision to v3.2.0. - Removed Dengue disease under Genetic and Rare Diseases Information Center resources (v3.1.0).SummaryDifference2%

- Check78 days agoChange DetectedContent shifts from pharmaceutical safety/solution terminology to general chemical/inorganic categories, and updates the revision to v3.1.0.SummaryDifference0.5%

- Check92 days agoChange DetectedRevision updated to v3.0.2 and 'Back to Top' removed. No substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunogenicity and Safety of Tetravalent Dengue Vaccine Clinical Trial page.